how do glp-1 drugs work Receptor Agonists as Treatments for Type 2 Diabetes Evolution of GLP‐1 Receptor Agonists
Description
doi: 10.1016/j.cmet.2018.03.001 21 ZhaoXWangMWenZLuZCuiLFuCet al
Patrick Catalano (Tufts University School of Medicine) for reading the manuscript and giving suggestions
2012;303(7):E899-907
Exendin-4, a glucagonlike peptide-1 receptor agonist, attenuates breast cancer growth by inhibiting NF-B activation
The American Journal of Medicine
